High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study
Overview
Authors
Affiliations
Background: Retreatment tuberculosis (TB) disease is common in high-prevalence settings. The risk of repeated episodes of recurrent TB is unknown. We calculated the rate of recurrent TB per subsequent episode by matching individual treatment episodes over a period of 13 years.
Methods: All recorded TB episodes in Cape Town between 2003 and 2016 were matched by probabilistic linkage of personal identifiers. Among individuals with a first episode notified in Cape Town and who completed their prior treatment successfully we estimated the recurrence rate stratified by subsequent episode and HIV status. We adjusted person-time to background mortality by age, sex, and HIV status.
Results: A total of 292 915 TB episodes among 263 848 individuals were included. The rate of recurrent TB was 16.4 per 1000 person-years (95% CI, 16.2-16.6), and increased per subsequent episode (8.4-fold increase, from 14.6 to 122.7 per 1000 from episode 2 to 6, respectively). These increases were similar stratified by HIV status. Rates among HIV positives were higher than among HIV negatives for episodes 2 and 3 (2- and 1.5-fold higher, respectively), and the same thereafter.
Conclusions: TB recurrence rates were high and increased per subsequent episode, independent of HIV status. This suggests that HIV infection is insufficient to explain the high burden of recurrence; it is more likely due to a high annual risk of infection combined with an increased risk of infection or progression to disease associated with a previous TB episode. The very high recurrence rates would justify increased TB surveillance of patients with >1 episode.
Recurrent Pulmonary Tuberculosis in China, 2005 to 2021.
Li T, Zhang B, Du X, Pei S, Jia Z, Zhao Y JAMA Netw Open. 2024; 7(8):e2427266.
PMID: 39133484 PMC: 11320166. DOI: 10.1001/jamanetworkopen.2024.27266.
Kim M, Kim Y, Jeong D, Kim S, Hong S, Park S Therap Adv Gastroenterol. 2024; 17:17562848241265013.
PMID: 39092170 PMC: 11292712. DOI: 10.1177/17562848241265013.
Post-tuberculosis treatment paradoxical reactions.
Hermans S, Akkerman O, Meintjes G, Grobusch M Infection. 2024; 52(5):2083-2095.
PMID: 38955990 PMC: 11499416. DOI: 10.1007/s15010-024-02310-0.
Pelissari D, Lima L, Pavinati G, Magnabosco G, de Barros Silva Junior J, Bartholomay P Rev Bras Epidemiol. 2024; 27:e240016.
PMID: 38655945 PMC: 11027432. DOI: 10.1590/1980-549720240016.
Role of B Cells in Mycobacterium Tuberculosis Infection.
Stewart P, Patel S, Comer A, Muneer S, Nawaz U, Quann V Vaccines (Basel). 2023; 11(5).
PMID: 37243059 PMC: 10222439. DOI: 10.3390/vaccines11050955.